Pharmacological chaperones are small molecules that interact with a protein to enhance folding and stability. Understanding the chemistry underlying the interaction of pharmacological chaperones with their target proteins will facilitate the design of more efficient drugs with greater therapeutic potential.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hopwood, J.J. & Brooks, D.A. in Organelle Diseases (eds. Applegarth, D.A., Dimmick, J.E. & Hall, J.G.) 7–35 (Chapman and Hall, London, 1997).
Lieberman, R.L. et al. Nat. Chem. Biol. 3, 101–107 (2007).
Sawkar, A.R. et al. Proc. Natl. Acad. Sci. USA 99, 15428–15433 (2002)
Fan, J.Q. et al. Nat. Med. 5, 112–115 (1999).
Helenius, A., Marquardt, T. & Braakman, I. Trends Cell Biol. 2, 227–231 (1992).
Brooks, D.A. FEBS Letters 409, 115–120 (1997).
Premkumar, L. et al. J. Biol. Chem. 280, 23915–23919 (2005).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
I have nothing to declare in relation to Gaucher disease, but do receive funding from a company for research purposes, on chemical chaperones.
Rights and permissions
About this article
Cite this article
Brooks, D. Getting into the fold. Nat Chem Biol 3, 84–85 (2007). https://doi.org/10.1038/nchembio0207-84
Issue Date:
DOI: https://doi.org/10.1038/nchembio0207-84
This article is cited by
-
Inhibitor screening of pharmacological chaperones for lysosomal β-glucocerebrosidase by capillary electrophoresis
Analytical and Bioanalytical Chemistry (2011)
-
N-glycan structure dictates extension of protein folding or onset of disposal
Nature Chemical Biology (2007)